Concepedia

Charles Adhav

CA

Statistics

Publications

3

Citations

38

H-Index

3

Active since

2020

Affiliations

Pfizer (India)(Current)

Charles Adhav is an author at Pfizer (India) specializing in janus kinase inhibitor therapy, disease activity measurement, and post hoc analysis.

Publications per year

2020–2022

3

Publications

3

Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus

Murlidhar Rajagopalan, A. J. Chitkara, Samir Dalwai et al. · Clinical Cosmetic and Investigational Dermatology · 2021 · 16 citations · Full text

, , +16

Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long‐term extension studies over 7 years

Arvind Chopra, Vineeta Shobha, S Chandrashekara et al. · International Journal of Rheumatic Diseases · 2020 · 12 citations · Full text

, , +14

Ceftazidime-avibactam plus metronidazole vs. meropenem in complicated intra-abdominal infections: Indian subset from RECLAIM

Prithi Rodgers, Shweta Kamat, Charles Adhav · The Journal of Infection in Developing Countries · 2022 · 10 citations · Full text

, , +10

1–3 of 3